@article{7f1fa98c4f1541c88abec4bd79bb2d8f,
title = "PD-L1 (Programmed Death Ligand 1) as a Marker of Acute Cellular Rejection after Heart Transplantation",
keywords = "biopsy, graft rejection, humans, myocarditis, upregulation",
author = "Arrush Choudhary and Brinkley, {D. Marshall} and Sepideh Besharati and Meijers, {Wouter C.} and Atkinson, {James B.} and Kaushik Amancherla and Qingfeng Zhu and Shi Huang and Nguyen, {Lee S.} and Salem, {Joe Elie} and Enrico Ammirati and Joann Lindenfeld and Anders, {Robert A.} and Javid Moslehi",
note = "Funding Information: Dr Moslehi and this work were supported by National Institutes of Health grants (R01HL141466, R01HL155990, and R01HL156021). Funding Information: Dr Salem has served as a consultant for Bristol Myers Squibb. Dr Lindenfeld has served as a consultant for Abbott, AstraZeneca, CVRx, Boehringer Ingelheim, Edwards LifeSciences, Impulse Dynamics, and VWave and is supported by grants from AstraZeneca, Volumetric, and Sensible Medical. Dr Moslehi has served on advisory boards for Bristol Myers Squibb, Takeda, Regeneron, Audentes, Deciphera, Ipsen, Janssen, Immuno-Core, Boston Biomedical, Amgen, Myovant, Triple Gene/Precigen, Cytokinetics, and AstraZeneca. The other authors report no conflicts.",
year = "2021",
month = oct,
day = "1",
doi = "10.1161/CIRCHEARTFAILURE.121.008563",
language = "English (US)",
volume = "14",
pages = "E008563",
journal = "Circulation: Heart Failure",
issn = "1941-3289",
publisher = "Lippincott Williams and Wilkins",
number = "10",
}